Phoenix, AZ (PRWEB) January 26, 2014

In its continuing effort to fight ovarian cancer, Colleens Dream Foundation has granted over $20,000 to Cleveland Clinic to fund ovarian cancer research being conducted by Dr. Angela H. Ting, according to Colleens Dream Foundation President Billy Cundiff.

"Working with Cleveland Clinic has been an amazing experience," says Cundiff. "We are excited to support Dr. Ting's research."

Dr. Ting, who is an Assistant Staff of Cleveland Clinic Lerner Research Institute, says her "scientific passion" is the study of epigenetics.

She says one of her goals for her work is to establish an epigenetic signature for chemo-resistance in ovarian cancer.

"Epigenetics is defined as modifications of DNA or chromatin that do not directly change the DNA sequence but can significantly influence gene expression and organizations of the genome," says Dr. Ting. "An "epigenetic signature" is a unique epigenetic pattern that distinguishes drug resistant ovarian cancers from those that are responsive to treatments."

She says the Colleens Dream Foundation grant will allow her to conduct follow up research -on earlier pilot studies- addressing this topic.

Go here to learn more about "epigenetic signatures."

"Raising awareness and promoting research are truly the most essential and powerful strategies to improve the management of ovarian cancer and to reduce suffering due to the disease. I feel very honored to be part of this effort and greatly admire the thoughtful generosity of Mr.Lanning and Mr.Cundiff to show their support through the Kicking for the Dream program."

Cundiff, who is the kicker for the Cleveland Browns, says the $20,000 grant money given to the Cleveland Clinic and Dr. Ting was raised through Kicking For The Dream, and a Colleens Dream Foundation "grant match."

See more here:
Colleen’s Dream Foundation Grants Over $20,000 to Cleveland Clinic for Ovarian Cancer Research

Comments are closed.